$ 11.56
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Target Price
The average target price of CBLL is 28 and suggests 143% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
